Evidence map›Paper›PMID 41127876›Full record

ArticleObesity pillars2025

Establishing a multidisciplinary bariatric arterial embolization program: A two-year clinical experience.

Adham Khalil, Alan J Kim, Lawrence J Cheskin, Selvi Rajagopal, Bill Morefield, Zoobia Chaudhry, Kimberly A Gudzune, Clifford R Weiss

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Obesity pillars, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Adham KhalilDivision of Vascular and Interventional Radiology, Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Alan J KimDivision of Vascular and Interventional Radiology, Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Lawrence J CheskinDepartment of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Selvi RajagopalDepartment of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Bill MorefieldDivision of Vascular and Interventional Radiology, Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Zoobia ChaudhryDepartment of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Kimberly A GudzuneDepartment of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Clifford R WeissDivision of Vascular and Interventional Radiology, Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Bariatric arterial embolization (BAE) is an emerging, minimally invasive, image-guided procedure for treating obesity in patients for whom nonoperative treatments have failed and metabolic-bariatric surgery is not an option. BAE has shown success in clinical studies, but guidance on integrating BAE into weight management programs (WMPs) is lacking. We describe our experience with building a multidisciplinary clinical program that integrates BAE into routine care for obesity. Methods: We conducted a retrospective, single-center observational case series of patients treated with BAE through our WMP between November 2021 and September 2023. Patient chart review was performed for the following criteria for consideration of BAE: had a body mass index ≥30 kg/m Results: Thirty-one patients were considered for BAE through the program. Of those, 9 patients were cleared for BAE and 5 patients (4 women and 1 man) eventually underwent BAE. The mean age of the embolized patients was 42 years (range: 28-56). The mean pre-procedure weight was 116 kg (range: 100-134). Patients achieved a mean total body weight loss of 7.0% at 4-5 months' follow-up and 4.2% at 12 months. BAE was performed successfully with only transient nausea and vomiting postoperatively. The mean cost for BAE was $14,329 US dollars. Conclusions: BAE offers an obesity treatment option with low complication risk and potential benefit when used as part of a comprehensive WMP. Close collaboration between interventional radiologists and obesity medicine physicians is key for success. BAE should be offered as a component within a comprehensive WMP rather than as a stand-alone procedure.

Indexed as

Bariatric embolizationObesityObesity managementWeight loss program

Identifiers

PMID41127876
PMCPMC12537563

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.